229.39USD-5.45%Mkt Cap: 32.46B $P/E: 42.27Today
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally. The company offers ONPATTRO for h…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
$12.48BUSD
Key Statistics
Company
Market Cap32.46B $
Enterprise Value30.36B $
Revenue (TTM)4.80B $
Gross Profit3.03B $
Net Income (TTM)313.75M $
Revenue/Share36.24 USD
Last Price229.39 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS02043Q1076
Valuation
P/E (Trailing)42.27
P/E (Forward)18.22
PEG0.46
EV/EBITDA28.79
EV/Revenue6.32
P/S6.39
P/B22.65
EPS (TTM)5.43
EPS (Forward)12.59
52W Range
197.8111% of range495.55
52W High495.55 USD
52W Low197.81 USD
Profitability
Gross Margin81.64%
Oper. Margin17.93%
EBITDA Margin21.95%
Profit Margin8.45%
ROE39.76%
ROA6.32%
Growth
Revenue Growth66.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF524.08M $
CapEx (TTM)58.70M $
FCF Margin5.65%
FCF Yield0.84%
Net Debt-320.66M $
Net Debt/EBITDA-0.30
Balance Sheet
Debt/Equity1.62
Current Ratio3.06
Quick Ratio2.79
Book Value/Sh10.13 USD
Cash/Share24.72 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)370.20 USD
Upside (mean)+61.4%
Target Range230.00 USD – 536.00 USD
$230.00+61.4% to mean$536.00
# Analysts26
Ownership
Shares Out.133.81M
Float133.24M
Insiders0.18%
Institutions101.69%
Short Interest
Short Ratio2.4d
Short % Float4.78%
Short % Out.3.59%
Shares Short4.80M
Short (prev mo.)5.80M
Technical
SMA 50267.75 (-14.3%)
SMA 200332.01 (-30.9%)
Beta0.28
S&P 52W Chg18.16%
Avg Vol (30d)2.11M
Avg Vol (10d)1.59M
Technical Indicators
RSI (14)48.4
MACD-13.5533
MACD Signal-16.2160
MACD Hist.+2.6627
BB Upper293.26 USD
BB Middle238.02 USD
BB Lower182.78 USD
BB Width46.42%
ATR (14)13.15 USD
Vol Ratio (20d)0.84x